Advertisement
UK markets open in 6 hours 57 minutes
  • NIKKEI 225

    39,928.77
    +17.97 (+0.05%)
     
  • HANG SENG

    16,595.97
    +6.57 (+0.04%)
     
  • CRUDE OIL

    78.57
    -0.17 (-0.22%)
     
  • GOLD FUTURES

    2,124.10
    -2.20 (-0.10%)
     
  • DOW

    38,989.83
    -97.57 (-0.25%)
     
  • Bitcoin GBP

    53,660.95
    +3,615.95 (+7.23%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,207.51
    -67.39 (-0.41%)
     
  • UK FTSE All Share

    4,174.28
    -22.84 (-0.54%)
     

South Korea Biosimilars Business and Investment Opportunities Report 2023

Company Logo
Company Logo

Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "South Korea Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering.

South Korea biosimilar market size is expected to record a CAGR of 21.6% during 2023-2027 to reach US$1,160.3 million by 2027, increasing from US$531.5 million in 2023. Over the last five years, the sector has recorded a CAGR of 23.1%.

This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users.

Reasons to Buy

  • In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in South Korea.

  • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.

  • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the South Korea.

Key Topics Covered:

1 South Korea Biosimilar Market Size and Forecast, 2018-2027

2 South Korea Biosimilar Market Share by Product, 2018-2027
2.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027
2.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027
2.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027
2.4 Biosimilar Market Size by Other Biosimilars, 2018-2027

3 South Korea Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-2027

4 South Korea Biosimilar Market Share by Insulin Biosimilars, 2018-2027

5 South Korea Biosimilar Market Share by Interferons Biosimilars, 2018-2027

6 South Korea Biosimilar Market Share by Other Biosimilars, 2018-2027

7 South Korea Biosimilar Market Share by Type of Cell, 2018-2027
7.1 Biosimilar Market Size by Mammalian Cell, 2018-2027
7.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027

8 South Korea Biosimilar Market Share by Imaging Technique, 2018-2027
8.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027
8.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027
8.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027
8.4 Biosimilar Market Size by Others, 2018-2027

9 South Korea Biosimilar Market Share by Procedure, 2018-2027
9.1 Biosimilar Market Size by Invasive Procedure, 2018-2027
9.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027

10 South Korea Biosimilar Market Share by Source of Manufacturing, 2018-2027
10.1 Biosimilar Market Size by In-House, 2018-2027
10.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027

11 South Korea Biosimilar Market Share by Applications, 2018-2027
11.1 Biosimilar Market Size by Oncology, 2018-2027
11.2 Biosimilar Market Size by Blood Disorders, 2018-2027
11.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027
11.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027
11.5 Biosimilar Market Size by Infectious Diseases, 2018-2027
11.6 Biosimilar Market Size by Others, 2018-2027

12 South Korea Biosimilar Market Share by Type of Technology, 2018-2027
12.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027
12.2 Biosimilar Market Size by Chromatography, 2018-2027
12.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027
12.4 Biosimilar Market Size by Electrophoresis, 2018-2027
12.5 Biosimilar Market Size by Others, 2018-2027

13 South Korea Biosimilar Market Share by End User, 2018-2027
13.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027
13.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027
13.3 Biosimilar Market Size by Others, 2018-2027

For more information about this report visit https://www.researchandmarkets.com/r/str3tw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900